The Ninth Annual Society for Biomolecular Screening Conference, the leading industry and scientific event in drug discovery and related technologies and disciplines, will be held at the Oregon Convention Center in Portland from Sunday, September 21 through Thursday, September 25, 2003.

More than 3000 eminent scientists, innovators, and researchers -- as well as industry analysts representing a broad range of disciplines and companies from around the world -- are expected to gather to learn about the latest trends and basic and applied research that are dramatically transforming the way new pharmaceuticals are developed. These emerging developments are expected to help optimize the drug discovery process, making it faster, more efficient, and more cost-effective.

Sponsored by the Society for Biomolecular Screening (SBS), the only non-profit international scientific society dedicated to drug discovery sciences, the annual conference highlights the growing trend towards an inter-disciplinary approach to the development of pharmaceuticals. Through numerous presentations, forums, and workshops, it also promotes close-knit alliances and networking between industry and academia, as well as inter-disciplinary education among thought leaders in the molecular sciences, including biology, chemistry, bioinformatics, genomics, pharmaceutics, and biotechnology.

The five-day conference will include keynotes, feature presentations, tutorials, and workshops on emerging techniques, emphasizing the growing integration of the sciences and their effects on drug development. Breaking news and breakthrough research will be presented, as well as the latest advances in genomics, proteomics, high-throughput screening, ADMET, imaging, medicinal (all therapeutic areas), combinatorial and organic chemistry, nanotechnology, fluorescence and luminescence, micro- and nano-scale bioscience, bioinformatics, in-vitro
'"/>

Contact: Jon Feldman
ahprjf@aol.com
212-496-6585
Society for Biomolecular Screening
9-Sep-2003